140
X.-H. Zhu et al. / Journal of Molecular Catalysis A: Chemical 393 (2014) 134–141
10.96 (s, 1H, NCHN), 8.87 (d, J = 4.4 Hz, 2H, Ph), 8.16 (d, J = 6.0 Hz,
2H, Ph), 7.90 (m, 4H, CHimidazole and CHpyrimidine), 7.59 (t, J = 4.8 Hz,
1H, CHpyrimidine), 6.32 (s, 2H, CH2 Ph), 2.56 (s, 3H, CH3C O).
13C NMR (CDCl3, 100 MHz, ppm): ı 197.71 (C O), 159.90 (pyrimi-
dine), 152.12 (NCN), 138.27 (Ph), 137.67 (Ph), 135.84 (pyrimidine),
135.78 (pyrimidine), 129.94 (Ph), 129.22 (Ph), 124.33 (CHimidazole),
122.51 (CHimidazole), 118.83 (pyrimidine), 53.07 (CH2 Ph), 26.91
(CH3C O). Elemental analysis calcd (%) for C16H15BrN4O: C 53.50,
H 4.21, N 15.60; found: C 53.52, H 4.23, N 15.61.
Synthesis of 6. Silver oxide (0.5equiv) was added to a solution
of 1 (0.2 mmol) in CH2Cl2 (10 mL). The suspension was stirred at
room temperature for 4–6 h under the exclusion of light. The sus-
pension was filtered to the solution of [Cp*IrCl2]2 (0.1 mmol) in
dichloromethane. After the mixture was stirred at room temper-
ature for 12 h, the suspension was filtered and the filtrate was
concentrated. The residue was purified by column chromatogra-
phy with CH2Cl2/CH3OH (100:1–50:1) and yielded a yellow solid.
Yield: 71 mg (58%). 1H NMR (CDCl3, 500 MHz, ppm): ı 7.93 (d, 2H,
J = 5.0 Hz, Ph), 7.47 (d, 2H, J = 10.0 Hz, Ph), 6.95 (d, 1H, J = 2.0 Hz,
CHimidazole), 6.66 (d, 1H, J = 2.0 Hz, CHimidazole), 6.20–6.17 (d, 1H,
J = 15.0 Hz, CH2 Ph), 5.21–5.18 (d, 1H, J = 14.5 Hz, CH2 Ph), 4.01
(s, 3H, N CH3), 2.59 (s, 3H, CH3C O), 1.60 (s, 15H, Cp*). 13C
NMR (CDCl3, 125 MHz, ppm): ı 197.63 (C O), 157.36 (C Ir), 142.15
(Ph), 136.70 (Ph), 128.59 (Ph), 128.55 (Ph), 123.66 (CHimidazole),
121.71 (CHimidazole), 88.87 (Cp*), 54.06 (CH2 Ph), 38.70 (N CH3),
26.61 (CH3C O), 9.15 (Cp*, CH3). Elemental analysis calcd (%) for
(Ph), 129.19 (Ph), 123.98 (CHimidazole), 121.26 (CHimidazole), 118.51
(pyrimidine), 93.21 (Cp*), 53.55 (CH2 Ph), 28.82 (CH3C O), 9.43
(Cp*, CH3). Elemental analysis calcd (%) for C26H29ClF6IrN4OP: C
39.72, H 3.72, N 7.13; found: C 40.26, H 4.10, N 7.57.
Synthesis of 10. Following the same procedure as described
for 6, reaction of 1 (0.2 mmol) with Ag2O (0.5 equiv) in CH2Cl2
(10 mL) and subsequently with [Ru(p-cymene)Cl2]2 (0.1 mmol)
yielded 10 as an gray solid. Yield: 57 mg (55%). 1H NMR(CDCl3,
400 MHz, ppm): ı 7.94–7.92 (d, 2H, J = 8.0 Hz, Ph), 7.40–7.38 (d, 2H,
J = 8.0 Hz, Ph), 7.03 (s, 1H, CHimidazole), 6.81 (s,1H,CHimidazole), 5.96
(br, 1H, CH2 Ph), 5.61 (br, 1H, CH2 Ph), 5.36 (s, 2H, Cymene),
5.04 (s, 2H, Cymene), 4.05 (s, 3H, CH3 imidazole), 2.95–2.69 (sep-
tuplet, 1H, Ph CH(CH3)2), 2.60 (s, 3H, CH3C O), 2.06 (s, 3H, CH3
cymene), 1.25–1.24 (d, 6H, J = 6.8 Hz, Ph CH(CH3)2). 13C NMR(CDCl3,
100 MHz, ppm): ı 197.79 (C O), 174.90 (C Ru), 142.95 (Ph),
136.72 (Ph), 128.80 (Ph), 128.15 (Ph), 124.47 (CHimidazole), 122.86
(CHimidazole), 108.87, 98.97, 85.73, 82.25 (Cymene), 54.54 (CH2 Ph),
39.80 (N CH3), 30.87 (CH(CH3)2 cymene), 26.78 (CH3C O), 22.28
(CH(CH3)2 cymene), 18.78 (CH3 cymene). Elemental analysis calcd (%)
for C23H28Cl2RuN2O: C 53.08, H 5.42, N 5.38; found: C 53.06, H 5.40,
N 5.37.
General procedure for hydrogen transformation. Ketone
(1.0 mmol) or imine (1.0 mmol), tBuOK (0.1 mmol) and cata-
lyst (0.01 mmol) were weighed into an oven-dried Schlenk flask.
Dry iPrOH (3.0 mL) was added to the flask, and the mixture was
refluxed for the time specified under nitrogen. The reaction was
cooled, and an aliquot was filtered through a pad of Celite and
the crude product was purified by column chromatography using
petroleum ether and ethyl acetate. The analytical data of all
products are consistent with the data reported in literature [2,3].
C
23H29Cl2IrN2O: C 45.09, H 4.77, N 4.57; found: C 45.10, H 4.78, N
4.55.
Synthesis of 7. Following the same procedure as described for 6,
reaction of 2 (0.2 mmol) with Ag2O (0.5equiv) in CH2Cl2 (10 mL) and
subsequently with [Cp*IrCl2]2 (0.1 mmol) yielded 7 as an orange
solid. Yield: 72 mg (50%). 1H NMR (CDCl3, 400 MHz, ppm): ı 8.00 (d,
2H, J = 7.6 Hz, Ph), 7.55 (d, 2H, J = 8.0 Hz, Ph), 6.87 (s, 2H, CHmesityl),
6.83 (s, 1H, CHimidazole), 6.67 (s, 1H, CHimidazole), 5.91–5.87 (d, 1H,
J = 12.0 Hz, CH2 Ph), 5.71–5.67 (d, 1H, J = 12.0 Hz, CH2 Ph), 2.61
(s, 3H, CH3C O), 2.31 (s, 3H, p-CH3 Ph), 2.10 (s, 6H, o-CH3 Ph),
1.51 (s, 15H, Cp*). 13C NMR (CDCl3, 100 MHz, ppm): ı 197.76 (C O),
155.19 (C Ir), 142.36 (Ph), 138.66 (Ph), 136.95 (Ph), 136.89 (Ph),
128.96 (Ph), 128.72 (Ph), 125.75 (CHimidazole), 121.58 (CHimidazole),
89.27 (Cp*), 55.81 (CH2 Ph), 28.79 (CH3C O), 21.37 (p-CH3 Ph),
19.18 (o-CH3 Ph), 9.35 (Cp*, CH3). Elemental analysis calcd (%) for
Intramolecular
C H activation of complex 6. Complex 6
(0.04 mmol) and tBuOK (1 eq) were weighed into an oven-dried
Schlenk flask. Dry iPrOH (3.0 mL) was added to the flask, and the
mixture was refluxed for 48 h under nitrogen. After cooling, the
mixture was filtered through a pad of Celite and the crude prod-
uct was purified by column chromatography using CH2Cl2/CH3OH
(1000:1 – 600:1) and yielded 6ꢀ as a yellow solid. Yield: 17 mg
(70%). 1H NMR (CDCl3, 500 MHz, ppm): ı 8.19 (d, 1H, J = 2.0 Hz,
Ph), 7.46–7.43 (q, 1H, J = 1.8 Hz, Ph), 7.04–7.02 (d, 1H, J = 8.0 Hz,
Ph), 6.98–6.96 (d, 1H, J = 2.0 Hz, CHimidazole), 6.93 (d, 1H, J = 2.0 Hz,
CHimidazole), 4.85–4.82 (d, 1H, J = 14.4 Hz, CH2 Ph), 4.73–4.68(d, 1H,
J = 14.0 Hz, CH2 Ph), 3.93 (s, 3H, N CH3), 2.59 (s, 3H, CH3C O), 1.68
(s, 15H, Cp*). 13C NMR (CDCl3, 125 MHz, ppm): ı 199.95 (C O),
156.65 (C Ir), 144.73 (Ph), 144.16 (Ph), 142.25 (Ph), 136.37 (Ph),
124.47 (Ph), 121.77 (Ph), 121.48 (CHimidazole), 120.55(CHimidazole),
90.37 (Cp*), 56.96 (CH2 Ph), 36.92 (N CH3), 29.72(CH3C O), 9.46
(Cp*, CH3). Elemental analysis calcd (%) for C23H28ClIrN2O: C 47.95,
H 4.90, N 4.86; found: C 47.57, H 4.78, N 4.56.
C
31H37Cl2IrN2O: C 51.95, H 5.20, N 3.91; found: C 51.97, H 5.21, N
3.93.
Synthesis of 8. Following the same procedure as described for 6,
reaction of 3 (0.2 mmol) with Ag2O (0.5 equiv) in CH2Cl2 (10 mL)
and subsequently with [Cp*IrCl2]2 (0.1 mmol) yielded 8 as a yel-
low solid. Yield: 102 mg (70%). 1H NMR (CDCl3, 400 MHz, ppm):
ı 7.95 (d, 4H, J = 8.0 Hz, Ph), 7.50 (d, 4H, J = 8.0 Hz, Ph), 6.70 (s, 2H,
NCHCHN), 6.22 (d, 2H, J = 15.2 Hz, CH2 Ph), 5.35 (d, 2H, J = 15.6 Hz,
CH2 Ph), 2.59 (s, 6H, CH3C O), 1.63 (s, 15H, Cp*). 13C NMR (CDCl3,
100 MHz, ppm): ı 197.74 (C O), 158.65 (C Ir), 141.97 (Ph), 136.90
(Ph), 128.83 (Ph), 128.68 (Ph), 122.30 (NCHCHN), 89.37 (Cp*), 54.41
(CH2 Ph), 28.80 (CH3C O), 9.38 (Cp*, CH3). Elemental analysis
calcd (%) for C31H35Cl2IrN2O2: C 50.95, H 4.83, N 3.83; found: C
50.94, H 4.84, N 3.85.
Synthesis of 9. Following the same procedure as described
for 6, reaction of 4 (0.2 mmol) with Ag2O (0.5equiv) in CH2Cl2
(10 mL) and subsequently with [Cp*IrCl2]2 (0.1 mmol) and KPF6
(0.1 mmol) yielded 9 as a bright yellow solid. Yield: 90 mg (54%).
1H NMR (CDCl3, 400 MHz, ppm): ı 8.93–8.86 (m, 2H, CHimidazole),
7.95 (d, 2H, J = 8.0 Hz, Ph), 7.83 (s, 1H, CHpyrimidine), 7.68–7.64 (m,
1H, CHpyrimidine), 7.61–7.59 (d, 2H, J = 8.0 Hz, Ph), 7.07–7.04 (m,
1H, CHpyrimidine), 5.58 (d, 2H, J = 14.0 Hz, CH2 Ph), 2.57 (s, 3H,
CH3C O), 1.83 (s, 15H, Cp*). 13C NMR (CDCl3, 100 MHz, ppm): ı
197.68 (C O), 166.29 (pyrimidine), 161.19 (pyrimidine), 159.48
(pyrimidine), 157.63 (C Ir), 138.86 (Ph), 137.58 (Ph), 129.31
General procedure for amine N-alkylation. Alcohol (1.00 mmol)
and amine (1.10 mmol) were weighed into an oven-dried Schlenk
˚
flask containing 4 A molecular sieves (60 mg). tBuOK (0.50 mmol)
was added, followed by dry toluene (0.50 mL). The mixture was
put under an atmosphere of nitrogen, and catalyst (0.01 mmol)
was added before stoppering the flask and immersing it in a pre-
heated oil bath (110 ◦C) for 48 h. Then, the solvent was evaporated
and the crude solid was purified by column chromatography using
petroleum ether and triethylamine. The analytical data of all prod-
ucts are consistent with the data reported in literature [6j,8,11e].
X-ray crystallography. Intensity data for the Ir complex 6 were
collected on Bruker Smart APEX (at 293 K), equipped with 2.4 kW
˚
sealed tube X-ray source (Mo-K␣ radiation, ꢂ = 0.71073 A) oper-
ating at 50 kV and 30 mA. A hemisphere of intensity data was
collected at room temperature with a scan width of 0.60◦ in ω.
Empirical absorption corrections were based on SADABS program
[14]. The structures were solved by direct methods and refined
by full-matrix least-squares refinement using the SHELXTL-97